Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030

Oct 2020| TBR769B| TBRC (Publisher)

Report Highlights

Including: By Disease: Diabetes; Arthritis & Chron's Disease; Cancer; Infectious Diseases; Other Autoimmune Disease; Others Diseases
By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies; Others
By Therapeutic Mechanism: TNF-Alpha; Lymphocyte Modulators; Interleukin Inhibitors; GPCR; Immunostimulants; Others
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Covering: Merck & Co.; GlaxoSmithKline; Novo Nordisk; ALK-Abello A/S; Aimmune Therapeutics, Inc.

Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics and biosimilars market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the oral biologics and biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global oral biologics and biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by therapeutic mechanism, by disease, molecule type and by distribution channel.
  • Market Characteristics – The market characteristics section of the report defines and explains the oral biologics & biosimilars market. This chapter includes different services covered in the report and basic definitions.
  • Supply Chain – The supply chain section of the report defines and explains the key players in the oxygen market supply chain.
  • Product Analysis – The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.
  • Product Pipeline Analysis – This chapter gives the information on oral biologics & biosimilars product pipeline analysis.
  • Customer Information– This chapters covers recent customers’ trends/preferences in the global oxygen market.
  • Trends And Strategies – This chapter describes the major trends shaping the global oxygen market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the oral biologics and biosimilars market R&D funding market.
  • Global Oral Biologics & Biosimilars Comparative Analysis Of Overall Biologics & Oral Biologics – This section describes oral biologics & biosimilars comparative analysis of overall biologics and oral biologics.
  • Global Oral Biologics & Biosimilars Rise & Evolution – This section describes oral biologics & biosimilars market rise and evolution.
  • Oral Biologics & Biosimilars Companies’ Investment In Research And Development – This section describes oral biologics & biosimilars companies’ investment in research and development
  • Major Oral Biologics & Biosimilars Developments By Disease – This section describes major oral biologics & biosimilars developments by disease.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Market Segmentation – This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.
  • Regional Analysis – This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.
  • Regional Market Size And Growth – This section contains the region’s market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape – This section covers details on the competitive landscape of the global oral biologics & biosimilars market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for pharmaceuticals providers in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

The global oral biologics and biosimilars market is segmented into -
By Disease: Diabetes; Arthritis & Chron's Disease; Cancer; Infectious Diseases; Other Autoimmune Disease; Others Diseases
By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies; Others
By Therapeutic Mechanism: TNF-Alpha; Lymphocyte Modulators; Interleukin Inhibitors; GPCR; Immunostimulants; Others 
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Merck & Co.; GlaxoSmithKline; Novo Nordisk; ALK-Abello A/S; Aimmune Therapeutics, Inc.

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Oral Biologics & Biosimilars Market, Product Analysis - Product Examples
  • Table 2 : AstraZeneca - Oral Biologics & Biosimilars Market Pipeline Analysis
  • Table 3 : RANI Therapeutics - Oral Biologics & Biosimilars Market Pipeline Analysis
  • Table 4 : Novo Nordisk A/S - Oral Biologics & Biosimilars Market Pipeline Analysis
  • Table 5 : Oramed Pharmaceuticals - Oral Biologics & Biosimilars Market Pipeline Analysis
  • Table 6 : Allena Pharmaceuticals - Oral Biologics & Biosimilars Market Pipeline Analysis
  • Table 7 : ALK-Abello - Oral Biologics & Biosimilars Market Pipeline Analysis
  • Table 8 : Others - Oral Biologics & Biosimilars Market Pipeline Analysis
  • Table 9 : Global Oral Biologics & Biosimilars Market, Comparative Analysis, Overall Biologics & Oral Biologics
  • Table 10 : Global Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 11 : Global Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 12 : Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 13 : Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 14 : Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 15 : Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 16 : Global Oral Biologics & Biosimilars Market, Segmentation By Therapeutic Mechanism Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 17 : Global Oral Biologics & Biosimilars Market, Segmentation By Therapeutic Mechanism Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 18 : Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 19 : Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 20 : Global Oral Biologics & Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 21 : Global Oral Biologics & Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 22 : Global Oral Biologics & Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 23 : Global Oral Biologics & Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 24 : Asia Pacific Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017 94
  • Table 25 : Asia Pacific Prevalence Of Asthma, 2014-2017
  • Table 26 : Asia Pacific Prevalence Of Diabetes, 2014-2017
  • Table 27 : Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 28 : Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
  • Table 29 : Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 30 : Asia-Pacific Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 31 : Asia-Pacific Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 32 : Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 33 : Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 34 : China Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017 110
  • Table 35 : China Prevalence Of Asthma, 2014-2017
  • Table 36 : China Prevalence Of Diabetes, 2014-2017
  • Table 37 : China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 38 : China Per Capita Net Disposable Income, 2015-2019, $
  • Table 39 : China Population By Age Group, 2015-2023, Thousands
  • Table 40 : China Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 41 : China Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 42 : China Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 43 : China Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 44 : India Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 45 : India Prevalence Of Asthma, 2014-2017
  • Table 46 : India Prevalence Of Diabetes, 2014-2017
  • Table 47 : India Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 48 : India Per Capita Net Disposable Income, 2015-2019, $
  • Table 49 : India Population By Age Group, 2015-2023, Thousands
  • Table 50 : India Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 51 : India Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 52 : India Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 53 : India Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 54 : Japan Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017 131
  • Table 55 : Japan Prevalence Of Asthma, 2014-2017
  • Table 56 : Japan Prevalence Of Diabetes, 2014-2017
  • Table 57 : Japan Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 58 : Japan Per Capita Net Disposable Income, 2015-2019, $
  • Table 59 : Japan Population By Age Group, 2015-2023, Thousands
  • Table 60 : Japan Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 61 : Japan Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 62 : Japan Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 63 : Japan Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 64 : Australia Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 65 : Australia Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 66 : Australia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 67 : Australia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 68 : Indonesia Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 69 : Indonesia Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 70 : Indonesia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 71 : Indonesia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 72 : South Korea Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 73 : South Korea Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 74 : South Korea Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 75 : South Korea Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 76 : Western Europe Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 77 : Western Europe Prevalence Of Asthma, 2014-2017
  • Table 78 : Western Europe Prevalence Of Diabetes, 2013-2017
  • Table 79 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 80 : Western Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 81 : Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 82 : Western Europe Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 83 : Western Europe Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 84 : Western Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 85 : Western Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 86 : UK Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 87 : UK Prevalence Of Diabetes, 2013-2017
  • Table 88 : UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 89 : UK Per Capita Net Disposable Income, 2015-2019, $
  • Table 90 : UK Population By Age Group, 2015-2023, Thousands
  • Table 91 : UK Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 92 : UK Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 93 : UK Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 94 : UK Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 95 : Germany Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 96 : Germany Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 97 : Germany Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 98 : Germany Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 99 : France Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 100 : France Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 101 : France Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 102 : France Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 103 : Eastern Europe Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 104 : Eastern Europe Prevalence Of Asthma, 2014-2017
  • Table 105 : Eastern Europe Prevalence Of Diabetes, 2014-2017
  • Table 106 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 107 : Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 108 : Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 109 : Eastern Europe Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 110 : Eastern Europe Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 111 : Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 112 : Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 113 : Russia Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 114 : Russia Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 115 : Russia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 116 : Russia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 117 : North America Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 118 : North America Prevalence Of Asthma, 2014-2017
  • Table 119 : North America Prevalence Of Diabetes, 2014-2017
  • Table 120 : North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 121 : North America Per Capita Net Disposable Income, 2015-2019, $
  • Table 122 : North America Population By Age Group, 2015-2023, Thousands
  • Table 123 : North America Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 124 : North America Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 125 : North America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 126 : North America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 127 : USA Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017 231
  • Table 128 : USA Prevalence Of Asthma, 2014-2017
  • Table 129 : USA Prevalence Of Diabetes, 2014-2017
  • Table 130 : USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 131 : USA Per Capita Net Disposable Income, 2015-2019, $
  • Table 132 : USA Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Market, Population By Age Group, 2015-2023, Thousands
  • Table 133 : USA Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 134 : USA Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 135 : USA Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 136 : USA Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 137 : South America Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 138 : South America Prevalence Of Asthma, 2014-2017
  • Table 139 : South America Prevalence Of Diabetes, 2013-2017
  • Table 140 : South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 141 : South America Population By Age Group, 2015-2023, Thousands
  • Table 142 : South America Per Capita Net Disposable Income, 2015-2019, $
  • Table 143 : South America Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 144 : South America Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 145 : South America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 146 : South America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 147 : Brazil Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 148 : Brazil Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 149 : Brazil Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 150 : Brazil Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 151 : Middle East Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 152 : Middle East Prevalence Of Diabetes, 2014-2017
  • Table 153 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 154 : Middle East Per Capita Net Disposable Income, 2015-2019, $
  • Table 155 : Middle East Population By Age Group, 2015-2023, Thousands
  • Table 156 : Middle East Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 157 : Middle East Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 158 : Middle East Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 159 : Middle East Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 160 : Africa Respiratory Infections And Tuberculosis Disease Prevalence, 2013-2017
  • Table 161 : Africa Prevalence Of Diabetes, 2013-2017
  • Table 162 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 163 : Africa Per Capita Net Disposable Income, 2015-2019, $
  • Table 164 : Africa Population By Age Group, 2015-2023, Thousands
  • Table 165 : Africa Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 166 : Africa Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 167 : Africa Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 168 : Africa Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 169 : Global Oral Biologics And Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 170 : Merck & Co. - Financial Performance, 2015-2019, $ Billion
  • Table 171 : GlaxoSmithKline - Financial Performance, 2015-2019, $ Billion
  • Table 172 : Novo Nordisk - Financial Performance, 2015-2019, $ Billion
  • Table 173 : ALK-Abello A/S - Financial Performance, $ Billion
  • Table 174 : Global Oral Biologics & Biosimilars Market Size Gain ($ Million), 2019 - 2023, By Country
  • Table 175 : Global Oral Biologics & Biosimilars Market Size Gain ($ Million), Segmentation By Disease, 2019 - 2023
  • Table 176 : Global Oral Biologics & Biosimilars Market Size Gain ($ Million), Segmentation By Molecule Type, 2019 - 2023
  • Table 177 : Global Oral Biologics & Biosimilars Market Size Gain ($ Million), Segmentation By Mechanism Type, 2019 - 2023
  • Table 178 : Global Oral Biologics & Biosimilars Market Size Gain ($ Million), Segmentation By Distribution Channel, 2019 - 2023
  • Table 179 : Oral Biologics & Biosimilars - Market Data Sources
  • Figure 1 : Global Oral Biologics & Biosimilars Market Segmentation By Disease
  • Figure 2 : Global Oral Biologics & Biosimilars Market Segmentation By Molecule Type
  • Figure 3 : Global Oral Biologics & Biosimilars Market Segmentation By Therapeutic Mechanism
  • Figure 4 : Global Oral Biologics & Biosimilars Market Segmentation By Distribution Channel
  • Figure 5 : Oral Biologics & Biosimilars Industry, Supply Chain Analysis
  • Figure 6 : Global Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 7 : Global Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 8 : Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 9 : Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 10 : Global Oral Biologics & Biosimilars Market, Segmentation By Therapeutic Mechanism Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 11 : Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 12 : Global Oral Biologics & Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 13 : Global Oral Biologics & Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 14 : Asia-Pacific Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 15 : Asia-Pacific Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 16 : Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 17 : China Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 18 : China Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 19 : China Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 20 : India Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 21 : India Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 22 : India Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 23 : Japan Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 24 : Japan Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 25 : Japan Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 26 : Australia Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 27 : Australia Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 28 : Australia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 29 : Indonesia Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 30 : Indonesia Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 31 : Indonesia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 32 : South Korea Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 33 : South Korea Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 34 : South Korea Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 35 : Western Europe Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 36 : Western Europe Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 37 : Western Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 38 : UK Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 39 : UK Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 40 : UK Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 41 : Germany Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 42 : Germany Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 43 : Germany Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 44 : France Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 45 : France Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 46 : France Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 47 : Eastern Europe Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 48 : Eastern Europe Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 49 : Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 50 : Russia Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 51 : Russia Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 52 : Russia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 53 : North America Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 54 : North America Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 55 : North America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 56 : USA Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 57 : USA Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 58 : USA Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 59 : South America Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 60 : South America Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 61 : South America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 62 : Brazil Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 63 : Brazil Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 64 : Brazil Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 65 : Middle East Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 66 : Middle East Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 67 : Middle East Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 68 : Africa Oral Biologics & Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 69 : Africa Oral Biologics & Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 70 : Africa Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 71 : Global Oral Biologics And Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 72 : Merck & Co. - Financial Performance, 2015-2019, $ Billion
  • Figure 73 : GlaxoSmithKline - Financial Performance, 2015-2019, $ Billion
  • Figure 74 : Novo Nordisk - Financial Performance, 2015-2019, $ Billion
  • Figure 75 : ALK-Abello A/S - Financial Performance, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report